Date published: 2026-5-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

PI 3-kinase Activator (CAS 1236188-16-1)

0.0(0)
Write a reviewAsk a question

See product citations (11)

Alternate Names:
Insulin receptor substrate (Tyr608) peptide; KKHTDDGYMPMSPGVA
Application:
PI 3-kinase activator is a synthetic activator of PI 3-kinase and an IRS-1 substrate
CAS Number:
1236188-16-1
Purity:
≥95%
Molecular Weight:
1732.80
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data.

QUICK LINKS

The PI 3-kinase activator, a compound designed to activate phosphoinositide 3-kinase (PI3K), plays a crucial role in scientific research by modulating intracellular signaling pathways involved in various cellular processes. PI3Ks are lipid kinases that phosphorylate phosphoinositides, leading to the activation of downstream signaling cascades implicated in cell growth, survival, proliferation, and metabolism. By activating PI3K, PI 3-kinase activators enhance the production of phosphatidylinositol (3,4,5)-trisphosphate (PIP3), which subsequently recruits and activates protein kinase B (Akt) and other signaling molecules. This activation of PI3K/Akt signaling pathway regulates diverse cellular functions, including cell cycle progression, protein synthesis, glucose metabolism, and cell survival. Research utilizing PI 3-kinase activators has provided insights into the molecular mechanisms underlying various physiological and pathological conditions, such as cancer, diabetes, cardiovascular diseases, and neurodegenerative disorders. Furthermore, PI 3-kinase activators have been instrumental in elucidating the crosstalk between PI3K signaling and other signaling pathways, highlighting their significance as valuable tools for investigating cellular signaling networks and identifying potential targets for disease intervention.


PI 3-kinase Activator (CAS 1236188-16-1) References

  1. Phosphatidylinositol 3-kinase activator reduces motor neuronal cell death induced by G93A or A4V mutant SOD1 gene.  |  Koh, SH., et al. 2005. Toxicology. 213: 45-55. PMID: 15996807
  2. Phosphatidylinositol-3-kinase activation blocks amyloid beta-induced neurotoxicity.  |  Lee, KY., et al. 2008. Toxicology. 243: 43-50. PMID: 17980476
  3. FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice.  |  Kamagate, A., et al. 2008. J Clin Invest. 118: 2347-64. PMID: 18497885
  4. L-DOPA-induced neurotoxicity is reduced by the activation of the PI3K signaling pathway.  |  Park, HH., et al. 2009. Toxicology. 265: 80-6. PMID: 19786063
  5. The early activation of PI3K strongly enhances the resistance of cortical neurons to hypoxic injury via the activation of downstream targets of the PI3K pathway and the normalization of the levels of PARP activity, ATP, and NAD⁺.  |  Noh, MY., et al. 2013. Mol Neurobiol. 47: 757-69. PMID: 23254998
  6. Differential effects of angiotensin II receptor blockers on Aβ generation.  |  Liu, J., et al. 2014. Neurosci Lett. 567: 51-6. PMID: 24680748
  7. Novel pyrrole carboxamide inhibitors of JAK2 as potential treatment of myeloproliferative disorders.  |  Brasca, MG., et al. 2015. Bioorg Med Chem. 23: 2387-407. PMID: 25882525
  8. The Key Role of Calmodulin in KRAS-Driven Adenocarcinomas.  |  Nussinov, R., et al. 2015. Mol Cancer Res. 13: 1265-73. PMID: 26085527
  9. Angiotensin type 1a receptor deficiency decreases amyloid β-protein generation and ameliorates brain amyloid pathology.  |  Liu, J., et al. 2015. Sci Rep. 5: 12059. PMID: 26154270
  10. Downregulated AEG-1 together with inhibited PI3K/Akt pathway is associated with reduced viability of motor neurons in an ALS model.  |  Yin, X., et al. 2015. Mol Cell Neurosci. 68: 303-13. PMID: 26320681
  11. Early Activation of Phosphatidylinositol 3-Kinase after Ischemic Stroke Reduces Infarct Volume and Improves Long-Term Behavior.  |  Kim, YS., et al. 2017. Mol Neurobiol. 54: 5375-5384. PMID: 27590139
  12. 15-Deoxy-Δ12,14-prostaglandin J2 induced neurotoxicity via suppressing phosphoinositide 3-kinase.  |  Koma, H., et al. 2017. Neuropharmacology. 113: 416-425. PMID: 27771378
  13. Characterization of the endogenous insulin receptor-related receptor in neuroblastomas.  |  Kovacina, KS. and Roth, RA. 1995. J Biol Chem. 270: 1881-7. PMID: 7829525
  14. Protein kinase C modulation of insulin receptor substrate-1 tyrosine phosphorylation requires serine 612.  |  De Fea, K. and Roth, RA. 1997. Biochemistry. 36: 12939-47. PMID: 9335553
  15. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase.  |  De Fea, K. and Roth, RA. 1997. J Biol Chem. 272: 31400-6. PMID: 9395471

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

PI 3-kinase Activator, 1 mg

sc-3036
1 mg
$125.00

PI 3-kinase activator, 10 mg

sc-3036A
10 mg
$1248.00

PI 3-kinase activator, 25 mg

sc-3036B
25 mg
$2705.00